Celltrion Group has announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted conditional ma...
Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Bioc...
Researchers from the School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU) have developed a ...
Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialise...
Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) has announced that MTPC and Takeda Pharmaceutical Company...
Sosei Group Corporation (Sosei Heptares) in Japan and PharmEnable, a UK drug discovery company, have announced...
FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new...
The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...
The Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development hosted by A*STAR...
Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...
Japanese firm Eisai Co., Ltd. and US based Wren Therapeutics Ltd. have announced that the companies have entered into an...
OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced...
New Zealand's Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, has ident...
Hong Kong-based Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecu...
Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...
Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced today that the ...
CStone Pharmaceuticals has announced a licensing agreement with LegoChem Biosciences, Inc., (LCB) for the development an...
ASLAN Pharmaceuticals, clinical-stage immunology focused biopharmaceutical company developing innovative treatments to t...
Prestige BioPharma Ltd. on 13 Oct 2020 announced that the European Medicines Agency (EMA) Orphan Drug Commission (C...
Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...
The University of Tokyo and Eisai Co., Ltd. have announced a collaboration aiming for the development and drug discovery...
Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...
Marinomed Biotech AG, a Vienna-based biopharmaceutical company, develops groundbreaking treatment for autoimmune gastrit...
South Korea based Standigm Inc., an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, ...
Excelra, a global data science and data analytics company headquartered in India, has announced its collaboration with S...
Eisai Co., Ltd. announced on 10 June 2020 that it has committed the equivalent of 1 million USD in aid towards various a...
India-based Sun Pharmaceutical Industries Ltd (Sun Pharma) has received Indian regulatory approval to start clinical tri...
Roche, a global leading provider of pharmaceuticals and cancer treatments, today announced that the Health Sciences Auth...
Exyte, world-renowned for the design and construction of high tech facilities, and Univercells Technologies, a prov...
Hong Kong based Insilico Medicine has announced that it has entered into a research collaboration agreement with Ja...
Taiwan headquartered Senhwa Biosciences Inc announced that it has partnered with the US National Institutes of Health (N...
US based Esperion has announced that the company has entered into a collaboration agreement with Otsuka Pharmaceutic...
Hong Kong headquartered Insilico Medicine has announced that it has entered into a research collaboration with Boehringe...
There is no specific drug which can fight against COVID-19 yet. Developing a specific drug is quite tough. It is no...
Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...
The Centre for Digestive Disease (CDD) headed by Professor Thomas Borody has cured Crohn’s Disease as reported on ...
Pfizer Inc.on 9 April 2020, announced important advances in the battle against the global COVID-19 pandemic. Some o...
Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...
I-Mab Biopharma, a clinical stage biopharmaceutical company committed to the discovery, development and commercializatio...
US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...
AnHeart Therapeutics, a clinical stage oncology company focused on underserved patients in global markets, has anno...
Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, on 23 March 2020 announced a research collaboratio...
Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...
Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Med...
AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...
US based Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, and South Korea based ...
Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...
Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. have concluded a license agreement concerning dotinurad (ge...
Arctoris Ltd, an Oxford-based company that operates the world’s first fully automated drug discovery platform, has...
Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies h...
Borui Bio-Pharmaceutical (Suzhou) Co., Ltd. announced that it has successfully developed and synthesizes the technology ...
US based biotech company Gilead is working with health authorities in China to establish a randomized, controlled trial ...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea has acquired ...
Astellas Pharma Inc. and FibroGen, Inc. has announced the submission of a supplemental New Drug Application (sNDA) to&nb...
Headquartered in Australia, Noxopharm Limited is a clinical stage drug development company that has been in the limeligh...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, introduced new workstations...
US based Inovio Pharmaceuticals, has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded In...
The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...
US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repai...
Hitachi Chemical Advanced Therapeutics Solutions, LLC, a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...
US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as ...
US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...
apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...
Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...
AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...
Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...
AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...
China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...
Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...
The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...
Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...
China based BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innova...
US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...
Roche has announced that the European Commission has approved Kadcyla® (trastuzumab emtansine) for the adjuvant (aft...
Pfizer and Japan based Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved a su...
AstraZeneca and Daiichi Sankyo Company presented positive detailed data from the global pivotal Phase II single-arm DEST...
Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in Chi...
Innovent Biologics, a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Ty...
Chugai Pharmaceutical has announced that the "New England Journal of Medicine" (NEJM) online edition November 27 R...
Astellas Pharma Inc., based in Tokyo, Japan has announced the China National Medical Products Administration ...
Pfizer Inc. on 25th Nov 2019, announced the efficacy and tolerability results from the subgroup analysis of Asian patien...
Merck, a leading science and technology company, on 25 Nov 2019, announced the presentation of multiple abstracts on tep...
BeiGene, Ltd., China, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative ...
South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo biotechnology c...
The State Food and Drug Administration of China (CFDA) has conditionally approved the application for the listing o...
South Korea headquartered Samsung Biologics has announced the signing of a long-term agreement with US based Ichnos Scie...
Merck and Pfizer Inc. on 29 Oct 2019, announced that the European Commission (EC) has approved BAVENCIO® (avelu...
Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administrati...
Japanese firm Takeda Pharmaceutical Company and US based COUR Pharmaceutical Development Company, Inc. have announ...
NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products,...
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) have announced that the US Food and Drug Administration...
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved REYVOW...
Gilead Sciences, Inc. has announced the New Drug Application (NDA) for filgotinib, an investigational, oral, select...
Bayer AG (Bayer), and RIKEN Innovation Co., Ltd. (RIKEN Innovation), have entered into a strategic collaboration agreeme...
Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) ta...
Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the...
Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has granted Breakt...
Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA)...
